[Chemotherapy for advanced non-small-cell lung cancer: combinations without platinium derivatives]

[Article in French]

J-L Pujol¹

Affiliations

¹ Service de Pneumologie-Phtisiologie, Clinique des maladies respiratoires, Hôpital Arnaud-de-Villeneuve, 371 avenue du Doyen-Gaston-Giraud, 34295 Montpellier Cedex 5, France.

Review

[Article in French]

J-L Pujol. Rev Pneumol Clin. 2004 Nov.

. 2004 Nov;60(5 Pt 3):4S17-4S19.

J-L Pujol¹

¹ Service de Pneumologie-Phtisiologie, Clinique des maladies respiratoires, Hôpital Arnaud-de-Villeneuve, 371 avenue du Doyen-Gaston-Giraud, 34295 Montpellier Cedex 5, France.

No abstract available

Similar articles

Chemotherapy for advanced non-small-cell lung cancer.
Raez LE, Lilenbaum R. Raez LE, et al. Clin Adv Hematol Oncol. 2004 Mar;2(3):173-8. Clin Adv Hematol Oncol. 2004. PMID: 16166948 Review.
[Chemotherapy in cancer of the lung].
Gütz S. Gütz S. MMW Fortschr Med. 2006 Jun 1;148(22):33-4. MMW Fortschr Med. 2006. PMID: 16821578 German.
Chemotherapy for advanced lung cancer.
Blackhall F, Thatcher N. Blackhall F, et al. Eur J Cancer. 2004 Nov;40(16):2345-8. doi: 10.1016/j.ejca.2004.06.026. Eur J Cancer. 2004. PMID: 15519503 No abstract available.
Toxicity data in addition to survival data are important in evaluating the applicability of a chemotherapy regimen of advanced non-small-cell lung cancer.
Hotta K, Matsuo K, Ueoka H. Hotta K, et al. Lung Cancer. 2005 Aug;49(2):277. doi: 10.1016/j.lungcan.2005.01.011. Lung Cancer. 2005. PMID: 15953658 No abstract available.
[Second-line chemotherapy in non-small-cell lung cancer].
Schütte W. Schütte W. Rev Pneumol Clin. 2004 Nov;60(5 Pt 3):4S13-4S16. Rev Pneumol Clin. 2004. PMID: 15687987 Review. French. No abstract available.